Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
621 participants
OBSERVATIONAL
2018-06-01
2022-01-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-void Bladder Scanning in Acute Cauda Equina Syndrome
NCT02806167
BLB Study Back or Leg Pain and Bladder Symptoms Study
NCT03325374
Neuro-urological Outcome After Spinal Cord Injury
NCT01297660
Understanding Perinatal Spinal Cord Injury
NCT06808035
Mechanisms of Orthostatic Intolerance in Spinal Cord Injured Individuals and Following Bed Rest
NCT00175773
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Cases will be identified by neurosurgical or orthopaedic trainees in each specialist centre through daily screening of tertiary referrals and admissions to specialist spinal services. All patients managed as CES by the treating team will be included in this audit. CES will be divided into CES suspected (CESS), CES incomplete (CESI), and CES retention (CESR).
Data regarding timing and type of symptom onset, referral, investigation, management, and outcome will be recorded anonymously on a secure database by the local trainee investigator during the patient's hospital admission and after discharge. Patient consent will be sought for the use of their data and patients will be asked to complete patient reported outcome measures representing their condition before surgery and up to one year after surgery. This data will be compared with care quality statements and published outcome data for CES.
The study will recruit for one year. Cases will be identified from admissions to spinal units between 1st June 2018 until 31st May 2019. The last one year follow up assessments will be sent to participants on 1st June 2020.
This is an observational study. No changes to routine patient care will occur during this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cauda Equina Syndrome
For inclusion in this study, the patient must:
* be over 18 years old;
* be admitted to a specialist spinal service in the UK between 1st June 2018 and 31st May 2019;
* have capacity to provide informed consent for participation in this study; and
* have a diagnosis of clinical CES and structural compression of the cauda equina on imaging as determined by the treating clinician.
* Clinical CES includes any disturbance of saddle sensation, bladder function, bowel function, sexual dysfunction and bilateral sciatica associated with radiological compression of the cauda equina. The cauda equina compression can be due to any cause, including, but not limited to, disc, tumour, infection, etc.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* be over 18 years old;
* be admitted to a specialist spinal service in the UK between 1st June 2018 and 31st May 2019;
* have capacity to provide informed consent for participation in this study; and
* have a diagnosis of clinical CES and structural compression of the cauda equina on imaging as determined by the treating clinician.
* Clinical CES includes any disturbance of saddle sensation, bladder function, bowel function, sexual dysfunction and bilateral sciatica associated with radiological compression of the cauda equina. The cauda equina compression can be due to any cause, including, but not limited to, disc, tumour, infection, etc.
Exclusion Criteria
* Patients undergoing emergent decompression for unilateral motor or sensory symptoms (eg foot drop), without clinical evidence of CES
* Patients referred with suspected CES where the diagnosis is not confirmed, for example:
o Patients with the clinical symptoms and signs of CES without radiological evidence of cauda equina compression
* Patients not admitted to participating spinal centres in the UK
* Patients admitted to a participating spinal centre before 1st June 2018 or after 31st May 2019
* Patients who are unable to provide informed consent for participation in this study
18 Years
120 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NHS Lothian
OTHER_GOV
University Hospitals of Derby and Burton NHS Foundation Trust
OTHER
Royal Brompton & Harefield NHS Foundation Trust
OTHER
East Kent Hospitals University NHS Foundation Trust
OTHER_GOV
Somerset NHS Foundation Trust
OTHER
Buckinghamshire Healthcare NHS Trust
OTHER
Milton Keynes University Hospital NHS Foundation Trust
OTHER_GOV
The Ipswich Hospital NHS Trust
OTHER
King's College Hospital NHS Trust
OTHER
Newcastle-upon-Tyne Hospitals NHS Trust
OTHER
University Hospital Southampton NHS Foundation Trust
OTHER
Royal Devon and Exeter NHS Foundation Trust
OTHER
Royal Cornwall Hospitals Trust
OTHER
Walton Centre NHS Foundation Trust
OTHER
South Tees Hospitals NHS Foundation Trust
OTHER
Lancashire Teaching Hospitals NHS Foundation Trust
OTHER
City Hospitals Sunderland NHS Foundation Trust
OTHER
Northern Care Alliance NHS Foundation Trust
OTHER
Hull University Teaching Hospitals NHS Trust
OTHER_GOV
The Leeds Teaching Hospitals NHS Trust
OTHER
Sheffield Teaching Hospitals NHS Foundation Trust
OTHER
Nottingham University Hospitals NHS Trust
OTHER
University Hospital Birmingham NHS Foundation Trust
OTHER
University Hospitals Coventry and Warwickshire NHS Trust
OTHER
Cambridge University Hospitals NHS Foundation Trust
OTHER
Norfolk and Norwich University Hospitals NHS Foundation Trust
OTHER
Oxford University Hospitals NHS Trust
OTHER
North Bristol NHS Trust
OTHER
University Hospital Plymouth NHS Trust
OTHER
Barts & The London NHS Trust
OTHER
Barking, Havering and Redbridge University Hospitals NHS Trust
OTHER
Brighton and Sussex University Hospitals NHS Trust
OTHER
St George's University Hospitals NHS Foundation Trust
OTHER
University College London Hospitals
OTHER
Imperial College Healthcare NHS Trust
OTHER
University of Edinburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julie Woodfield, MBChB PhD
Role: STUDY_CHAIR
University of Edinburgh
Aimun Jamjoom
Role: STUDY_DIRECTOR
University of Edinburgh
Ingrid Hoeritzauer, MBBChBAO
Role: STUDY_DIRECTOR
University of Edinburgh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Neurosciences, Western General Hospital
Edinburgh, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
160318
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.